Drug intelligence / Profile preview

N-Cyclohexyl-N'-Decylurea

Development stage: Unknown
Modality: Small Molecules

Overview

N-Cyclohexyl-N'-Decylurea is a synthetic small molecule belonging to the urea class of organic compounds. It features both a cyclohexyl and a decyl group attached to the urea core, giving it amphipathic properties with both hydrophilic (urea) and hydrophobic (alkyl) characteristics. This compound has been investigated as an inhibitor of bifunctional epoxide hydrolase 2, an enzyme involved in the metabolism of epoxides. Its primary use is experimental and investigative; there are no approved medical indications or clinical trials beyond preclinical research[1][2]. The compound's unique solubility profile makes it potentially useful in chemical research and formulation science[7].

Other names: Urea, N-cyclohexyl-N'-decyl-

Targets

EPHX2 (Soluble epoxide hydrolase)

Beyond the preview

Go deeper on N-Cyclohexyl-N'-Decylurea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Cyclohexyl-N'-Decylurea.

Explore the full profile